Halaman 2 - Kemoterapi untuk karsinoma esofagus Dokter Terbaik - TOP-40 dokter

Profesor Madya Nail Paksoy memimpin uji klinis untuk protokol kemoterapi tingkat lanjut di Rumah Sakit Medipol Bahçelievler.

• Bersertifikat Dewan ESMO dalam Onkologi Medis
• Spesialisasi lebih dari 5 tahun dalam kanker gastrointestinal
• Menulis berbagai publikasi tentang hasil kemoterapi
• Bekerja dengan kombinasi obat terbaru yang disetujui FDA

Dr. Auala Hubert memimpin Pusat Kanker Gastrointestinal di Hadassah Medical Center, berspesialisasi dalam karsinoma esofagus dengan 33 tahun pengalaman.

• Kepala Pusat Kanker Gastrointestinal di Hadassah University Hospital
• Bersertifikat Dewan (Board-certified) dalam bidang Onkologi dan Radioterapi
• Anggota Masyarakat Onkologi Klinis Israel dan Asosiasi Kanker Israel
• Fasih berbahasa Inggris dan Ibrani untuk pasien internasional

Dr. Alemdar berspesialisasi dalam onkologi medis dengan pelatihan ekstensif di Universitas Akdeniz – pemimpin dalam perawatan kanker.

• Bersertifikat dewan dalam onkologi medis sejak 2018
• Lebih dari 7 tahun fokus secara eksklusif pada pengobatan onkologi
• Dilatih di Rumah Sakit Universitas Akdeniz – pusat kanker utama Turki
• Berspesialisasi dalam protokol kemoterapi untuk kanker gastrointestinal

Prof. Madya Atakan Topcu berspesialisasi dalam onkologi medis dengan fokus pada tumor padat, termasuk karsinoma esofagus, di Rumah Sakit Distrik Medipol Acibadem.

• Telah menerbitkan lebih dari 50 artikel ilmiah di bidang onkologi
• Pakar dalam terapi tertarget dan imunoterapi
• Anggota Masyarakat Onkologi Medis Eropa (ESMO)
• Berspesialisasi dalam malnutrisi terkait kanker dan onkologi geriatri

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Profesor Madya Muhammed Mustafa Atci berspesialisasi dalam kemoterapi karsinoma esofagus di Liv Hospital Topkapı, dengan pengalaman onkologi lebih dari satu dekade.

• Anggota American Society of Clinical Oncology (ASCO)
• Telah menerbitkan lebih dari 19 artikel yang ditinjau sejawat tentang pengobatan onkologi
• Berspesialisasi dalam protokol kemoterapi tingkat lanjut untuk karsinoma esofagus
• Koordinator Pendidikan untuk Onkologi Medis di Rumah Sakit Kota Cemil Taşcıoğlu

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Osama Abdel Mohimen Mohamed is Head of the Hematology Unit at Shefaa Al Orman Oncology Hospitals. He is also a consultant in medical oncology and hematology at Shefa El Orman Hospital (NGO), Luxor (2019–present).

He diagnoses and treats acute and chronic leukemia, lymphoma, myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms. He also manages complications of solid tumors.

Background: He served at the National Cancer Institute, Cairo University, as a medical oncology resident, then demonstrator and assistant lecturer (2008–2022). Earlier, he was a house officer (2006–2007). He also held specialist roles at Al Salam International, Al Molalmen, and BAHEYA Oncology Center (NGO).

Memberships: ESMO (2008–present). American Society of Bone Marrow Transplantation (2009). ASH (2010).

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Sridhar P.S. berspesialisasi dalam radioterapi dan kemoterapi untuk karsinoma esofagus di HCG Manavata Cancer Centre.

• Pengalaman lebih dari 20 tahun di bidang onkologi radiasi
• Diplomate of National Board dalam radioterapi
• Anggota Association of Radiation Oncology of India
• Bagian dari Bangalore Oncology Group

Menangani lebih dari 30.000 pemindaian PET dan 1.000 pasien kanker tiroid – Dr. Borde berspesialisasi dalam kedokteran nuklir di HCG Manavata Cancer Centre.

• 12 tahun pengalaman dalam kedokteran nuklir
• Keahlian dalam terapi radioiodin & Lu-177 RN
• Makalah yang diterbitkan di berbagai jurnal medis

Dr. Raj Nagarkar telah melakukan 50.000+ operasi kanker, spesialisasi dalam Onkologi Bedah Payudara dan Toraks di HCG Manavata Cancer Centre.

• 19 tahun pengalaman onkologi bedah
• Terlatih di Tata Memorial Hospital dan Royal College of Surgeons
• Terlibat dalam 200+ uji klinis
• Profesor untuk DNB Superspecialty Surgical Oncology

Dr. Shaunak Valame berspesialisasi dalam kemoterapi untuk karsinoma esofagus dengan fokus kuat pada terapi target dan penelitian molekuler.

• Terlatih dalam Onkologi Medis di Rumah Sakit Indraprastha Apollo
• Mempresentasikan penelitian tentang kanker lambung di simposium ASCO
• Berpengalaman dalam praktik klinis dan akademisi

10.000+ operasi besar dilakukan selama 10 tahun – Dr. Banswal berspesialisasi dalam bedah kanker gastrointestinal dengan fokus pada teknik invasif minimal.

• Pelatihan fellowship dalam onkologi bedah di Tata Medical Centre
• Ahli dalam bedah kanker invasif minimal dengan hasil yang sangat baik
• Co-principal investigator dalam berbagai proyek penelitian asli
• Dipublikasikan di jurnal nasional dan internasional

Spesialisasi dalam preservasi organ dan rehabilitasi fungsional untuk pasien kanker mulut – kunci kualitas hidup pada karsinoma esofagus.

• 3 tahun pengalaman onkologi bedah di HCG Manavata Cancer Centre
• Pelatihan Fellowship dalam Onkologi Bedah Kepala & Leher
• Mahir dalam bedah mayor maksilofasial serta kepala & leher
• Fokus pada kebersihan mulut preventif dan diagnosis dini kanker

Dr. Shruti Kate berspesialisasi dalam kemoterapi tingkat lanjut untuk karsinoma esofagus, dengan keahlian dalam imunoterapi dan terapi metronomik. Terlatih di Tata Memorial Hospital – salah satu pusat kanker terkemuka di India.

• DM dalam Onkologi Medis dari Tata Memorial Hospital, Mumbai
• Anggota ASCO, ESMO, dan perkumpulan onkologi terkemuka lainnya
• Mempresentasikan penelitian di Konferensi Dunia tentang Kanker Paru
• Pengalaman mengobati tumor padat, termasuk kanker paru-paru dan esofagus